Nkarta inc.

Major-Pharmaceuticals

NKTX


Executive/
Director

Price

  • Last Close
  • $ 2.5
    $ -0 -0.2 %
    Jan 3, 2025
  • 52-Week High/Low
  • $15.71 - $1.31
  • YTD
  • 0%

  • Trading Volume
  • 22,305
  • Market Cap Full
  • $ 122.7M
  • Shares Outstanding
  • 49.1M
    Nov 6, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% -46.5% -25.9% -40.7% 71.2% -
Q2 - - - - 4% -3.7% 8.3% -38.3% -45.8% -
Q3 - - - - 8% -12.2% 6.8% -36.5% -14.4% -
Q4 - - - - 104.5% -44.8% -54.5% 403.8% 0.8% -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 37% 33.6% -6.5% -35.8% -6.2% -13.7% 9.5% -14.4% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%-75%-61%10%-62%0%

Earnings

2021 2022 2023
Q1 -0.59 -0.79 -0.63
Q2 -0.66 -0.61 -0.68
Q3 -0.68 -0.58 -0.52
Q4 -0.69 -0.63 -
A -2.6 -2.6 -1.83

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 32.8 33 48.9
Jun - 32.8 48.4 48.9
Sep 32.7 32.9 48.7 49.1
Dec 32.6 32.9 48.8 49.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 23.8 - -1.3 22 -
Equity multiplier 0.2 0.1 - -0.2 -